Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.
Current and emerging therapies for multiple sclerosis.
Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial.
PGE2 contributes to in vitro MSC-mediated inhibition of non-specific- and antigen-specific T cells proliferation in MS patients.
Undifferentiated MSCs are able to myelinate DRG neuron processes through p75.
Tai Chi Chuan in Medicine and Health Promotion.
Multiple sclerosis: Etiology, incidence and prevalence.
Sarcoidosis with neurological involvement imitating multiple sclerosis: The importance of thoracic imaging.
Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis.
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple Sclerosis.
Intracortical inhibition abnormality during the remission phase of multiple sclerosis is related to upper limb dexterity and lesions.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Biochemical Pharmacology of the Sigma-1 Receptor.
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.
The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry.
Cryoglobulinaemia (IgG-κ-type and IgM-γ-type) with Occluding Leukocytoclastic Vasculitis in a Patient with Vitiligo and Demyelinating Polyneuropathy.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Using conceptual work products of case management to design health IT.
Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.
European multiple sclerosis risk variants in the south Asian population.
Human neural progenitor cells in central nervous system lesions.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Pages
« first
‹ previous
…
542
543
544
545
546
547
548
549
550
…
next ›
last »